Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan
Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...
Sam Altman reportedly backs $1B round for AI healthcare startup Retro Biosciences
Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...
eWeek5d
Sam Altman’s AI Briefing: Super-Agents To Revolutionize Software, Finance, and More
OpenAI CEO Sam Altman will brief U.S. officials on super-agents—AI systems set to revolutionize software development, finance ...
Sam Altman’s World now wants to link AI agents to your digital identity
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
Sam Altman-Backed Retro Biosciences Raising $1 Billion to Extend Human Lifespan
Sam Altman, the CEO of OpenAI, is backing a groundbreaking initiative aimed at extending human lifespan by a decade through ...
Joe Biden's parting gift to Elon Musk: 2 11th-hour filings that bolster the tech big's beef with Sam Altman, Microsoft
WIth one foot out the White House door, the Biden administration issued 2 documents Musk is now using in his battle to break ...
Investor's Business Daily on MSN2d
Cathie Wood Dumps Sam Altman's Surging Nuclear Startup; Buys Key Uranium Player
Cathie Wood and her Ark Invest funds sold Oklo — the nuclear power startup backed by OpenAI head Sam Altman — and purchased ...